Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gustavo Torres-Franco"'
Autor:
Mario Fragoso-Saavedra, Carmen Ramírez-Estudillo, Diana L. Peláez-González, Jorge O. Ramos-Flores, Gustavo Torres-Franco, Leandro Núñez-Muñoz, Gabriel Marcelino-Pérez, María G. Segura-Covarrubias, Rogelio González-González, Roberto Ruiz-Medrano, Beatriz Xoconostle-Cázares, Amanda Gayosso-Vázquez, Silvia Reyes-Maya, Vianey Ramírez-Andoney, Rogelio A. Alonso-Morales, Marco A. Vega-López
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
New vaccine design approaches, platforms, and immunization strategies might foster antiviral mucosal effector and memory responses to reduce asymptomatic infection and transmission in vaccinated individuals. Here, we investigated a combined parentera
Externí odkaz:
https://doaj.org/article/73aa18dbf5df4c9eb37f018789f89d0f
Autor:
Leandro Núñez-Muñoz, Gabriel Marcelino-Pérez, Berenice Calderón-Pérez, Miriam Pérez-Saldívar, Karla Acosta-Virgen, Hugo González-Conchillos, Brenda Vargas-Hernández, Ana Olivares-Martínez, Roberto Ruiz-Medrano, Daniela Roa-Velázquez, Edgar Morales-Ríos, Jorge Ramos-Flores, Gustavo Torres-Franco, Diana Peláez-González, Jorge Fernández-Hernández, Martha Espinosa-Cantellano, Diana Tapia-Sidas, José Abrahan Ramírez-Pool, América Padilla-Viveros, Beatriz Xoconostle-Cázares
Publikováno v:
Vaccines, Vol 9, Iss 8, p 928 (2021)
The Receptor-Binding Domain (RBD) of the Spike (S) protein from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has glycosylation sites which can limit the production of reliable antigens expressed in prokaryotic platforms, due to glycan
Externí odkaz:
https://doaj.org/article/9334bd9b0c7642c7a44b08eefd119a42
Autor:
Hugo González-Conchillos, Gabriel Marcelino-Pérez, Daniela Roa-Velázquez, Edgar Morales-Ríos, Roberto Ruiz-Medrano, America Padilla-Viveros, Diana Tapia-Sidas, Martha Espinosa-Cantellano, Gustavo Torres-Franco, Karla Acosta-Virgen, Leandro Nuñez-Muñoz, Ana Olivares-Martínez, Jorge Ramos-Flores, Diana Peláez-González, Brenda Vargas-Hernández, José Abrahan Ramírez-Pool, Berenice Calderón-Pérez, Jorge Fernández-Hernández, Miriam Pérez-Saldívar, Beatriz Xoconostle-Cázares
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 928, p 928 (2021)
Volume 9
Issue 8
Vaccines, Vol 9, Iss 928, p 928 (2021)
Volume 9
Issue 8
The Receptor-Binding Domain (RBD) of the Spike (S) protein from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has glycosylation sites which can limit the production of reliable antigens expressed in prokaryotic platforms, due to glycan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0d509bfb391953612229ec4dc8e2b76
https://pubmed.ncbi.nlm.nih.gov/34452053
https://pubmed.ncbi.nlm.nih.gov/34452053